Use of the nirB promoter to direct the stable expression of heterologous antigens in salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine

Bio/Technology

Volumn 10, Issue 8, 1992, Pages 888-892

  Chatfield, S N ^a   Charles, I G ^b   Makoif, A J ^b   Oxer, M D ^b   Dougan, G ^a   Pickard, D ^a   Slater, D ^b   Fairweather, N F ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL VACCINE; TETANUS TOXIN; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; GENE EXPRESSION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA; VACCINATION;

ANAEROBIOSIS; ANIMAL; ANTIBODIES; GENE EXPRESSION; IMMUNIZATION; KINETICS; MICE; MICE, INBRED BALB C; NITRITE REDUCTASES; PLASMIDS; PROMOTER REGIONS (GENETICS); SALMONELLA TYPHIMURIUM; TETANUS TOXIN; TETANUS TOXOID;

ANIMALIA; SALMONELLA;

EID: 14744302999     PISSN: 0733222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0892-888     Document Type: Article

References (27)

1. Germanier, R. and Furer, K. 1975. Isolation and characterisation of galE mutant Ty21a of Salmonella typhi: a candidate strain for a live oral typhoid vaccine J. Infect. Dis. 131: 553-558.
2. Levine, M. M., Fericcio, C., Black, R. E., Germanier, R. and Chilean Typhoid Committee. 1987. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric coated capsule formulation. Lancet (i): 1049-1052.
3. Hoiseth, S. K. and Stocker, B. A. D. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291: 238-240.
4. O’Callaghan, D., Maskell, D., Liew, F. Y., Easmon, C. S. F. and Dougan, G. 1988. Characterisation of aromatic-and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56: 419-426.
5. Mukkur, T. K. S., McDowell, G. N., Stocker, B. A. D. and Lascelles, A. K. 1987. Protection against salmonellosis in mice and sheep by immunisation with aromatic-dependent Salmonella typhimurium. J. Med. Microbiol. 24: 11-19.
6. Jones, P. W., Dougan, G., Hayward, C., Mackensie, N., Collins, P. and Chatfield, S. N. 1991. Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium. Vaccine 9: 29-36.
7. Casper, G. L., Nicholas, R. A. J., Cullen, G. A. and Hormache, C. E. 1990. Vaccination of chickens w’ith a Salmonella enteritidis aroA live oral Salmonella vaccine. Microbiol. Pathogen. 9: 255-265.
8. Dougan, G., Hofnung, M., Lanzavecchia, A. and Leclerc, C. Immune response to proteins with recombinant epitopes, perspectives for vaccines, p. 171-220. In: Conferences Philipe Laudat 1990 INSERM, Paris.
9. Newton, S. M. C., Jacob, C. O. and Stocker, B, A. D. 1989. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244: 70-72.
10. Tite, J. P., Gao, X-M., Hughes, Jenkins, M., Lipscombe, M., O’Callaghan, D., Dougan, G. and Liew, F. Y. 1990. Anti-viral immunity induccd by recombinant nucleoprotein of Influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a liver carrier. Immunology 70: 540-547.
11. Sadoff, J. C, Ballou, W. R., Baron, L. S., Majarian, W. R., Brey, R. N., Hockmeyer, W. T., Young, J. F., Cryz, J. J., Ou. J., Lowell, G. H. and Chulay, J. D. 1988. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240: 236-238.
12. Fairweather, N. F., Chatfield, S. N., Makoff, A. J., Strugnell, R. A., Bester, J., Maskell, D. J. and Dougan, G. 1990. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun. 58: 1323-1329.
13. Chatfield, S. N., Fairweather, N. E, Charles, I., Pickard, D., Levine, M., Hone, D., Posada, M., Strugnell, R. A. and Dougan, G. 1992. Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Infect. Immun: 10: 53-60.
14. Stanfield, J. P. and Galazka, A. 1984. Neonatal tetanus in the third world today. Bull. WHO 62: 647-669.
15. Amann, E., Brosius, J. and Ptashne, M. 1983. Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. Gene 25: 167-178.
16. Peakman, T., Crouzet, J., Jayaux, J. E, Busby, S., Mohan, S., Harborne, N., Wooton, J., Nicholson, R. and Cole, J. 1990. Nucleotide sequence, organisation and structural analysis of the products of genes in the nirB-cysB region of the Escherichia coli K-12 chromosome. Eur. f. Biochem. 191: 315-323.
17. Oxer, M. D., Bently, C. M., Doyle, J. G., Peakman, T. C., Charles, I. G. and Makoff, A. J. 1991. High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. Nucl. Acids Res. 19: 1889-1892.
18. Bullas, L. R. and Ryu, J-I. 1983. Salmonella typhimurium LT2 strains which are r-m + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156: 471-474.
19. Hone, D., Attridge, S., Van den Bosch, L. and Hacketl, J. 1988. A chromosomal integration system for stabilisation of heterologous genes in Salmonella based vaccine strains. Microbial Pathogen. 5: 407-418.
20. Nakayama, K., Kelly, S. M. and Curtiss, R. 1988. Construction of an Asd expression-cloning vector: stable maintenance and high levels expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6: 693-697.
21. Strugnell, R. A., Maskell, D., Fairweather, N., Pickard, D, Cockayne, A., Penn, C. and Dougan, G. 1990. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88: 57-63.
22. Jayaraman, P. S., Peakman, T. C., Busby, S. J. W., Quincey, R. V. and Cole, J. A. 1987. Location and sequence of the promoter of the gene for the NADH-dependent nitrite reductase of Escherichia coli and its regulation by oxygen, the Fnr protein and nitrite. J. Mol. Biol. 196: 781-788.
23. Bell, A. I., Gaston, K. L., Cole, J. A. and Busby, S. J. W. 1989. Cloning of binding sequences for the Escherichia coli transcription activators, FNR and CRP: location of bases involved in discrimination between FNR and CRP. Nucl. Acids Res. 17: 3865-3874.
24. Jayaraman, P. S., Cole, J. A. and Busby, S. J. W. 1989. Mutational analysis of the nucleotide sequence at the FNR-depcndent nirB promoter in Escherichia coli. Nucl. Acids Res. 17: 135-145.
25. Stover, C. K., de la Cruz, V. E, Fuerst, X R., Burlein, J. E., Benson. L. A., Bennet, L. X, Bansal, G. P., Young, J. E, Lee, M. H., Hatful, G. F, Snapper, S. B., Barletta, R. G., Jacobs, W. R. and Bloom, B. R. 1991. New use of BCG for recombinant vaccines. Nature 351: 456-460.
26. Davis, R. W, Bostein, D. and Roth, J. R, 1980. Advanced Bacterial Genetics. A Manual for Genetic Engineering. Gold Spring Harbor Laboratory, Cold Spring Harbor, NY.
27. Makoff, A. J., Oxer, M. D, Romanos, M. A., Fairweather, N. F. and Ballantine, S. 1989. Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. Nucl. Acids Res. 17: 10191-10202.